Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $2.04 in the prior trading day, Milestone Pharmaceuticals Inc (NASDAQ: MIST) closed at $1.89, down -7.35%. In other words, the price has decreased by -$7.35 from its previous closing price. On the day, 1.47 million shares were traded.
Ratios:
Our goal is to gain a better understanding of MIST by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 15.40 and its Current Ratio is at 15.40. In the meantime, Its Debt-to-Equity ratio is 2.25 whereas as Long-Term Debt/Eq ratio is at 2.23.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $9.
On June 20, 2023, Jefferies Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $8 to $4.
Piper Sandler Upgraded its Neutral to Overweight on April 22, 2022, whereas the target price for the stock was revised from $8 to $10.
Stock Price History:
Over the past 52 weeks, MIST has reached a high of $2.75, while it has fallen to a 52-week low of $1.12. The 50-Day Moving Average of the stock is -7.13%, while the 200-Day Moving Average is calculated to be 13.44%.
Shares Statistics:
A total of 53.33M shares are outstanding, with a floating share count of 50.76M. Insiders hold about 4.81% of the company’s shares, while institutions hold 42.47% stake in the company.
